Company Filing History:
Years Active: 2012-2013
Title: Anthonina Janssen: Innovator in Antibody Detection
Introduction
Anthonina Janssen is a notable inventor based in Schiphorst, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the detection of antibodies related to borrelia infections. With a total of 2 patents, his work has the potential to impact the healthcare industry positively.
Latest Patents
Janssen's latest patents focus on polypeptides and methods for the specific detection of antibodies in patients with borrelia infections. The first patent discloses proteins derived from OspC from bacteria of the genus, specifically a protein that comprises a first OspC polypeptide linked to a second OspC polypeptide via a disulphide bridge. This innovation also includes methods for detecting antibodies against OspC and a diagnostic kit and vaccine against the infection.
Career Highlights
Anthonina Janssen is associated with Euroimmun Medizinische Labordiagnostika AG, a company known for its advancements in medical laboratory diagnostics. His work at Euroimmun has allowed him to focus on innovative solutions for antibody detection, contributing to the company's reputation in the field.
Collaborations
Janssen has collaborated with notable colleagues, including Lars Komorowski and Christian Probst. These partnerships have fostered a collaborative environment that enhances the development of innovative diagnostic methods.
Conclusion
Anthonina Janssen's contributions to the field of medical diagnostics through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the detection of borrelia infections, showcasing the importance of innovation in healthcare.